Consistently, the infarction size (% area at risk) in PTPIP51 knockdown hearts after I/R was significantly smaller than the control hearts, while the areas at risk (% left ventricular) showed no significant difference between the two groups, based on Evan’s Blue-TTC double staining (Fig. 2H). This evidence concerns the gene RMDN3 and infarction.